Well-woman visit of mothers and human papillomavirus vaccine intent and uptake among their 9-17 year old children

作者：Rahman Mahbubur^*; Elam Lee B; Balat Michael I; Berenson Abbey B

来源：Vaccine, 2013, 31(47): 5544-5548.

DOI：10.1016/j.vaccine.2013.09.017

• Human papillomavirus vaccine
• Vaccine uptake
• Vaccine intent
• Well-woman visit

Objective: To examine the association between attending a well-woman clinic in the prior 2 years and obtaining the human papillomavirus (HPV) vaccine for their 9-17-year-old child.
Methods: Women (n = 1256) who attended reproductive health clinics during September 2011 to February 2013 and had >= 1 children 9-17 years of age were asked to complete a self-administered questionnaire containing questions on demographic characteristics, prior well-woman visits, HPV awareness, and HPV vaccine intent and uptake among their adolescent children.
Results: Nearly 78% of women reported having undergone a well-woman visit during the past 2 years. Bivariate analysis showed that the HPV vaccine initiation (23.9% vs. 14.0%, P=.004) and completion (13.6% vs. 6.7%, P=.011) among 9-17 daughters differed between mothers who did or did not have a well-woman visit during the past 2 years. However, intent to vaccinate them (47.2% vs. 53.3%, P=.173) did not differ between these two groups. With regard to 9-17 year old sons, vaccine initiation (10.1% vs. 9.6%, P=.871), completion (4.6% vs. 2.4%, P=.273) and intent to vaccinate (47.3% vs. 52.1%, P=.311) did not differ between these two groups. Multivariable logistic regression analyses confirmed the findings of these bivariate analyses after adjusting for confounder variables.
Conclusion: The well-woman visit may be a missed opportunity for physicians to educate their patients about the benefits of HPV vaccination for their adolescent children in general and sons in particular. Intervention studies are warranted to assess the benefits of using this setting to improve HPV vaccine uptake in the US.

• 出版日期2013-11-12